Status:
RECRUITING
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
Lead Sponsor:
CND Life Sciences
Collaborating Sponsors:
Oregon Health and Science University
Conditions:
PARKINSON DISEASE (Disorder)
Parkinson
Eligibility:
All Genders
40-99 years
Brief Summary
The goal of this observational study is to learn whether tissue samples taken from the colon during routine colonoscopy can detect signs of Parkinson's disease. The main question it aims to answer is:...
Detailed Description
Brief Summary What is this study about? This study is testing whether doctors can detect signs of Parkinson's disease by taking small tissue samples from the colon during a routine colonoscopy. Resea...
Eligibility Criteria
Inclusion
- Adults 40 to 99 years of age
- Patients with a confirmed clinical diagnosis of Parkinson's disease by UKPDS Brain Bank Criteria
- Patients who have agreed to undergo a routine colonoscopy as part of their surveillance for colon cancer or exclusion of other gastrointestinal diseases
Exclusion
- Use of anticoagulants (Plavix 75 mg or aspirin up to 325 mg alone is allowed)
- History of colon cancer
- Recent gastrointestinal illness or surgical procedures
- Pregnant or planning to become pregnant before the scheduled colonoscopy
- Significant cognitive impairment, as determined by study investigators
- Decisionally impaired adults who cannot express understanding that this study is voluntary and for research purposes
Key Trial Info
Start Date :
September 3 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2029
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT07204652
Start Date
September 3 2025
End Date
September 1 2029
Last Update
October 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Science University
Portland, Oregon, United States, 97239